Search

Jeffrey T. Palenik

Examiner (ID: 8947, Phone: (571)270-1966 , Office: P/1615 )

Most Active Art Unit
1615
Art Unit(s)
1615
Total Applications
1192
Issued Applications
644
Pending Applications
99
Abandoned Applications
467

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17355208 [patent_doc_number] => 20220016004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-20 [patent_title] => ANTIPERSPIRANT OR DEODORANT COMPOSITION [patent_app_type] => utility [patent_app_number] => 17/293610 [patent_app_country] => US [patent_app_date] => 2020-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8893 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17293610 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/293610
ANTIPERSPIRANT OR DEODORANT COMPOSITION Jan 15, 2020 Abandoned
Array ( [id] => 17472575 [patent_doc_number] => 20220080079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-17 [patent_title] => FLUORAPATITE-CONTAINING STRUCTURES STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH [patent_app_type] => utility [patent_app_number] => 17/420589 [patent_app_country] => US [patent_app_date] => 2020-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11316 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17420589 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/420589
FLUORAPATITE-CONTAINING STRUCTURES STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH Jan 8, 2020 Pending
Array ( [id] => 17426770 [patent_doc_number] => 20220054478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-24 [patent_title] => MINIMIZATION OF SYSTEMIC INFLAMMATION [patent_app_type] => utility [patent_app_number] => 17/420300 [patent_app_country] => US [patent_app_date] => 2020-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 80371 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17420300 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/420300
MINIMIZATION OF SYSTEMIC INFLAMMATION Jan 2, 2020 Pending
Array ( [id] => 16963089 [patent_doc_number] => 20210214588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-15 [patent_title] => LAMINATED ADHESIVE SHEET FOR SKIN [patent_app_type] => utility [patent_app_number] => 17/059845 [patent_app_country] => US [patent_app_date] => 2019-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5088 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17059845 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/059845
LAMINATED ADHESIVE SHEET FOR SKIN Dec 26, 2019 Abandoned
Array ( [id] => 19410581 [patent_doc_number] => 12076373 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-09-03 [patent_title] => Formulations for oral administration of active agents [patent_app_type] => utility [patent_app_number] => 16/724400 [patent_app_country] => US [patent_app_date] => 2019-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 31579 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16724400 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/724400
Formulations for oral administration of active agents Dec 22, 2019 Issued
Array ( [id] => 15861237 [patent_doc_number] => 20200138022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-07 [patent_title] => SELF INDICATING ANTIMICROBIAL CHEMISTRY [patent_app_type] => utility [patent_app_number] => 16/723486 [patent_app_country] => US [patent_app_date] => 2019-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16565 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16723486 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/723486
Self indicating antimicrobial chemistry Dec 19, 2019 Issued
Array ( [id] => 16197371 [patent_doc_number] => 10722507 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-07-28 [patent_title] => Multi-phase delivery compositions and products incorporating such compositions [patent_app_type] => utility [patent_app_number] => 16/718562 [patent_app_country] => US [patent_app_date] => 2019-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 13115 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16718562 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/718562
Multi-phase delivery compositions and products incorporating such compositions Dec 17, 2019 Issued
Array ( [id] => 20547525 [patent_doc_number] => 12558297 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-02-24 [patent_title] => Consumer product with controlled release, biodegradable core-shell microcapsule compositions [patent_app_type] => utility [patent_app_number] => 17/602073 [patent_app_country] => US [patent_app_date] => 2019-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30712 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17602073 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/602073
Consumer product with controlled release, biodegradable core-shell microcapsule compositions Dec 16, 2019 Issued
Array ( [id] => 20882424 [patent_doc_number] => 12698459 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-08-04 [patent_title] => Controlled release, biodegradable core-shell microcapsule compositions [patent_app_type] => utility [patent_app_number] => 17/602032 [patent_app_country] => US [patent_app_date] => 2019-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24025 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17602032 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/602032
CONTROLLED RELEASE, BIODEGRADABLE CORE-SHELL MICROCAPSULE COMPOSITIONS Dec 16, 2019 Pending
Array ( [id] => 16052885 [patent_doc_number] => 20200188297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-18 [patent_title] => LXR Agonist in Topical Ophthalmic Formulation for Treatment of Dry-Eye Disorder [patent_app_type] => utility [patent_app_number] => 16/711646 [patent_app_country] => US [patent_app_date] => 2019-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5725 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16711646 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/711646
LXR Agonist in Topical Ophthalmic Formulation for Treatment of Dry-Eye Disorder Dec 11, 2019 Abandoned
Array ( [id] => 15765781 [patent_doc_number] => 20200113908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-16 [patent_title] => COMPOSITIONS AND METHODS OF USE OF CIS-4-[2-{[(3S,4R)-3-FLUOROOXAN-4-YL]AMINO}-8-(2,4,6-TRICHLOROANILINO)-9H-PURIN-9-YL]-1-METHYLCYCLOHEXANE-1-CARBOXAMIDE [patent_app_type] => utility [patent_app_number] => 16/710533 [patent_app_country] => US [patent_app_date] => 2019-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25003 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16710533 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/710533
Compositions and methods of use of cis-4-[2-{[3S,4R)-3-fluorooxan-4-yl]amino}8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1-methylcyclohexane-1-carboxamide Dec 10, 2019 Issued
Array ( [id] => 15974447 [patent_doc_number] => 10667521 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-06-02 [patent_title] => Antimicrobial material comprising synergistic combinations of metal oxides [patent_app_type] => utility [patent_app_number] => 16/703342 [patent_app_country] => US [patent_app_date] => 2019-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 13 [patent_no_of_words] => 19586 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16703342 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/703342
Antimicrobial material comprising synergistic combinations of metal oxides Dec 3, 2019 Issued
Array ( [id] => 17355401 [patent_doc_number] => 20220016197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-20 [patent_title] => ZINGIBER ZERUMBET EXTRACT FOR COMBATING DANDRUFF [patent_app_type] => utility [patent_app_number] => 17/295993 [patent_app_country] => US [patent_app_date] => 2019-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3531 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17295993 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/295993
ZINGIBER ZERUMBET EXTRACT FOR COMBATING DANDRUFF Dec 3, 2019 Abandoned
Array ( [id] => 15990123 [patent_doc_number] => 20200170932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-04 [patent_title] => EXTENDED RELEASE L-TRI-IODOTHYRONINE SAFELY NORMALIZES KEY ELEMENTS OF MOLECULAR PATHOLOGY IN ALZHEIMERS DISEASE [patent_app_type] => utility [patent_app_number] => 16/702067 [patent_app_country] => US [patent_app_date] => 2019-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9867 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16702067 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/702067
EXTENDED RELEASE L-TRI-IODOTHYRONINE SAFELY NORMALIZES KEY ELEMENTS OF MOLECULAR PATHOLOGY IN ALZHEIMERS DISEASE Dec 2, 2019 Abandoned
Array ( [id] => 15707521 [patent_doc_number] => 20200100526 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-02 [patent_title] => Composition and Method for Reducing or Treating Oral Inflammation [patent_app_type] => utility [patent_app_number] => 16/700204 [patent_app_country] => US [patent_app_date] => 2019-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6549 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16700204 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/700204
Composition and method for reducing or treating oral inflammation Dec 1, 2019 Issued
Array ( [id] => 17334399 [patent_doc_number] => 20220000730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-06 [patent_title] => CLAY MASK COMPOSITION AND METHOD FOR USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/291268 [patent_app_country] => US [patent_app_date] => 2019-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4293 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17291268 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/291268
CLAY MASK COMPOSITION AND METHOD FOR USING THE SAME Nov 27, 2019 Abandoned
Array ( [id] => 16852779 [patent_doc_number] => 20210153524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-27 [patent_title] => Drinking Formulation for Maintaining Urinary Tract Health in Cats [patent_app_type] => utility [patent_app_number] => 16/697778 [patent_app_country] => US [patent_app_date] => 2019-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3014 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16697778 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/697778
Drinking Formulation for Maintaining Urinary Tract Health in Cats Nov 26, 2019 Abandoned
Array ( [id] => 17342057 [patent_doc_number] => 20220008388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-13 [patent_title] => COMBINATION OF GABOXADOL AND LITHIUM FOR THE TREATMENT OF PSYCHIATRIC DISORDERS [patent_app_type] => utility [patent_app_number] => 17/295870 [patent_app_country] => US [patent_app_date] => 2019-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24208 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17295870 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/295870
COMBINATION OF GABOXADOL AND LITHIUM FOR THE TREATMENT OF PSYCHIATRIC DISORDERS Nov 20, 2019 Abandoned
Array ( [id] => 20848684 [patent_doc_number] => 12685701 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-07-21 [patent_title] => Cosmetic make-up composition with long-lasting skin-perfecting effect [patent_app_type] => utility [patent_app_number] => 17/295571 [patent_app_country] => US [patent_app_date] => 2019-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2545 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17295571 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/295571
COSMETIC MAKE-UP COMPOSITION WITH LONG-LASTING SKIN-PERFECTING EFFECT Nov 19, 2019 Issued
Array ( [id] => 16052833 [patent_doc_number] => 20200188271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-18 [patent_title] => SPRAYABLE COSMETIC COMPOSITION [patent_app_type] => utility [patent_app_number] => 16/689626 [patent_app_country] => US [patent_app_date] => 2019-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12431 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16689626 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/689626
SPRAYABLE COSMETIC COMPOSITION Nov 19, 2019 Abandoned
Menu